Anthony S. Welters

Insider Reports History

Reporting-owner location: Washington, DC
Latest reporting-owner signature: /s/ Anne K. Frederick, by Power of Attorney for Anthony S. Welters
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Anthony S. Welters

Form 4 holding Director

Carlyle Group Inc.

Security class: Common Stock
Shares / value: 47,849
Estimated value: $2,315,413
Report date: 01 May 2026
Price: $48.39
Ownership: Direct

Form 4 holding Director

GILEAD SCIENCES, INC.

Security class: Common Stock
Shares / value: 12,894
Estimated value: $1,797,036
Report date: 30 Apr 2026
Price: $139.37
Ownership: Direct

Form 4 holding Director

LOEWS CORP

Security class: Common Stock
Shares / value: 9,845
Estimated value: $855,235
Report date: 03 Mar 2025
Price: $86.87
Ownership: Direct

Form 4 holding Director

LOEWS CORP

Security class: Restricted Stock Units
Shares / value: 1,288
Estimated value: $99,704
Report date: 14 May 2024
Price: $77.41
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

GILEAD SCIENCES, INC.

Security class: Non-qualified Stock Option (Right to Buy)
Shares / value: 12,648
Estimated value
Report date: 08 May 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

GILEAD SCIENCES, INC.

Security class: Non-qualified Stock Option (Right to Buy)
Shares / value: 4,884
Estimated value
Report date: 30 Apr 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

LOEWS CORP

Security class: Stock Appreciation Right
Shares / value: 0
Estimated value
Report date: 03 Mar 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Anthony S. Welters

4 CG

Carlyle Group Inc.

Report period: 01 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 May 2026, 18:27
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES, INC.

Report period: 30 Apr 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 May 2026, 16:22
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 25 Nov 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 25 Nov 2025, 17:02
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES, INC.

Report period: 07 May 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 08 May 2025, 18:27
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 01 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 May 2025, 16:24
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 03 Mar 2025
Transactions: 4
Transaction value: -$104,106
Accepted by SEC: 04 Mar 2025, 16:17
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 02 Dec 2024
Transactions: 4
Transaction value: -$99,641
Accepted by SEC: 03 Dec 2024, 16:16
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 27 Nov 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Nov 2024, 16:58
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 03 Sep 2024
Transactions: 4
Transaction value: -$88,729
Accepted by SEC: 04 Sep 2024, 16:15
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 03 Jun 2024
Transactions: 4
Transaction value: -$72,949
Accepted by SEC: 04 Jun 2024, 16:17
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 14 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 May 2024, 16:35
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 09 May 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 09 May 2024, 08:40
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES, INC.

Report period: 08 May 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 09 May 2024, 17:23
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 01 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 May 2024, 17:28
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 01 Mar 2024
Transactions: 4
Transaction value: -$71,268
Accepted by SEC: 04 Mar 2024, 19:04
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 01 Dec 2023
Transactions: 4
Transaction value: -$50,097
Accepted by SEC: 04 Dec 2023, 16:23
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 09 May 2023
Transactions: 3
Transaction value: $0
Accepted by SEC: 10 May 2023, 15:54
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES, INC.

Report period: 03 May 2023
Transactions: 2
Transaction value: +$808,245
Accepted by SEC: 04 May 2023, 17:47
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 01 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 May 2023, 17:04
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 21 Dec 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Dec 2022, 09:23
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 10 May 2022
Transactions: 3
Transaction value: $0
Accepted by SEC: 11 May 2022, 15:54
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES, INC.

Report period: 05 May 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 06 May 2022, 18:45
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES, INC.

Report period: 03 May 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 03 May 2022, 20:00
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 01 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 May 2022, 18:12
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 01 Jan 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 Jan 2022, 07:36
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 14 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Dec 2021, 09:05
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 13 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Dec 2021, 13:02
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 08 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Dec 2021, 17:15
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES INC

Report period: 22 Oct 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 26 Oct 2021, 15:31
Role: Director
Next action: Open filing details

4 CG

Carlyle Group Inc.

Report period: 31 Aug 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Sep 2021, 16:30
Role: Director
Next action: Open filing details

4 GILD

GILEAD SCIENCES INC

Report period: 12 May 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 14 May 2021, 15:56
Role: Director
Next action: Open filing details

4 L

LOEWS CORP

Report period: 11 May 2021
Transactions: 3
Transaction value: $0
Accepted by SEC: 12 May 2021, 11:12
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .